Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

OSPREY ILIAC: Occlusive/Stenotic Peripheral Artery REvascularization StudY for Common and/or External ILIAC Artery Using the Misago® RX Self-expanding Peripheral Stent

NCT02793492 is registered in ClinicalTrials.gov with Terumo Medical Corporation as lead sponsor.

NCT NCT02793492
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02793492 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
OSPREY ILIAC: Occlusive/Stenotic Peripheral Artery REvascularization StudY for Common and/or External ILIAC Artery Using the Misago® RX Self-expanding Peripheral Stent
Lead sponsor
Terumo Medical Corporation
Phase
Not applicable
Overall status
Completed
Start date
August 30, 2022
Completion date
July 1, 2026
Enrollment
75 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

iliac artery stenosis